ArticleDiabetes care2011
Endothelial factors and diabetic nephropathy.
Article in Diabetes care, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Association of eNOS and MCP-1 Genetic Variants with Type 2 Diabetes and Diabetic Nephropathy Susceptibility: A Case-Control and Meta-Analysis Study.Biochemical genetics · 2021Pooled it
- The effects of ursodeoxycholic acid on albuminuria in people with type 1 diabetes and diabetic kidney disease: a proof-of-concept study.Frontiers in endocrinology · 2026Trial
- Isoquercitrin Alleviates Diabetic Nephropathy by Inhibiting STAT3 Phosphorylation and Dimerization.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- Multi-Target Glitazones for Modulating Peroxisome Proliferator-Activated Receptor-γ, Cyclooxygenase-2, and Carbonic Anhydrases for the Management of Metabolic Dysfunction.ACS pharmacology & translational science · 2025Article
- GPR56 Promotes Diabetic Kidney Disease Through eNOS Regulation in Glomerular Endothelial Cells.Diabetes · 2023Article
- Transplantation of Human Amniotic Mesenchymal Stem Cells Up-Regulates Angiogenic Factor Expression to Attenuate Diabetic Kidney Disease in Rats.Diabetes, metabolic syndrome and obesity : targets and therapy · 2023Article
- LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-Journal of the American Society of Nephrology : JASN · 2019Article
- Article
- Urinary biomarkers for early diabetic nephropathy: beyond albuminuria.Pediatric nephrology (Berlin, Germany) · 2015Review
- Effect of uncontrolled hyperglycemia on levels of adhesion molecules in patients with diabetes mellitus type 2.Journal of Zhejiang University. Science. B · 2015Article
- Endothelial and platelet markers in diabetes mellitus type 2.World journal of diabetes · 2015Review
- Podocyte-specific VEGF-a gain of function induces nodular glomerulosclerosis in eNOS null mice.Journal of the American Society of Nephrology : JASN · 2014Article
- Elevated soluble VEGF receptor sFlt-1 correlates with endothelial injury in IgA nephropathy.PloS one · 2014Article
- Vascular endothelial growth factor-receptor 1 inhibition aggravates diabetic nephropathy through eNOS signaling pathway in db/db mice.PloS one · 2014Article
- Increased inner ear susceptibility to noise injury in mice with streptozotocin-induced diabetes.Diabetes · 2012Article
- VEGF and podocytes in diabetic nephropathy.Seminars in nephrology · 2012Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.